Mutz Christopher sold ANIP
February 12, 2026 · Form 4 insider transaction
Mutz Christopher sold 7,032 shares of ANI Pharmaceuticals, Inc. at $76.55 per share, a transaction worth $538.3K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 5 days after the transaction.
Direction
Disposed (sell-side)
Shares
7,032
Price
$76.55
Total value
$538.3K
InsiderMutz Christopher
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateFebruary 12, 2026
Filing dateFebruary 17, 2026
Shares owned after92,566
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2025.; The shares were sold in multiple trades at prices ranging from $75.43 to $76.92. The price reported above reflects the weighted average sales price.